Tvardi Therapeutics Revenue

Biotechnology Research • Houston, Texas, United States • 11-20 Employees

Tvardi Therapeutics revenue & valuation

Annual revenue	$1,200,000
Revenue per employee	$60,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,900,000
Total funding	$72,400,000

Key Contacts at Tvardi Therapeutics

Susan Shiff

Board Director

Imran Alibhai

Chief Executive Officer

Michael Lewis

Co-Founder Tvardi Therapeutics Inc.

Company overview

Headquarters	2450 Holcombe Blvd, Suite X, Houston, TX 77021, US
Phone number	+18324131362
Websites	tvardi.com tvarditherapeutics.com
NAICS	541714
SIC	873
Keywords	Cancer, Inflammation, Small Molecules, Fibrosis, Stat3
Founded	2017
Employees	11-20
Socials

Tvardi Therapeutics Email Formats

Tvardi Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@tvardi.com), used 53.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@tvardi.com	53.3%
{first name}{last name}	johndoe@tvardi.com	40%
{first initial}{f2}	j{f2}@tvardi.com	6.7%

About Tvardi Therapeutics

Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708).

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

Vice President

C-Suite

Employees by Department

Tvardi Therapeutics has 12 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Tvardi Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-15	5	$72,400,000

Funding Insights

$72,400,000

Total funding amount

$72,400,000

Most recent funding amount

Number of funding rounds

Tvardi Therapeutics Tech Stack

Discover the technologies and tools that power Tvardi Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MySQL

Databases

WordPress

Blogs

Nginx

Reverse proxies

PHP

Programming languages

Frequently asked questions

Tvardi Therapeutics is located in Houston, Texas, US.

You can reach Tvardi Therapeutics at +18324131362.

Tvardi Therapeutics generates an estimated annual revenue of $1,200,000. This revenue figure reflects the company's market position and business performance in its industry.

Tvardi Therapeutics has an estimated valuation of $3,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Tvardi Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Tvardi Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Tvardi Therapeutics has raised a total of $72,400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.